The 2011 Import and Export Market for Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used as Hormones Excluding Medicaments in Canada

On the demand side, exporters and strategic planners focusing on natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments in Canada face a number of questions. Which countries are supplying natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments to Canada? How important is Canada compared to others in terms of the entire global and regional market? How much do the imports of natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments vary from one country of origin to another in Canada? On the supply side, Canada also exports natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments. Which countries receive the most exports from Canada? How are these exports concentrated across buyers? What is the value of these exports and which countries are the largest buyers?

This report was created for strategic planners, international marketing executives and import/export managers who are concerned with the market for natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments in Canada. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics which appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments for those countries serving Canada via exports, or supplying from Canada via imports. It does so for the current year based on a variety of key historical indicators and econometric models.

In what follows, Chapter 2 begins by summarizing where Canada fits into the world market for imported and exported natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments. The total level of imports and exports on a worldwide basis, and those for Canada in particular, is estimated using a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the share that Canada is likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize Canada compared to other major country markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information sources for strategic planning purposes.

After the worldwide summary in Chapter 2 of both imports and exports of natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments, Chapter 3 goes into detail on imports, but for each major country of origin serving Canada. A “major” market is defined as a country where Canada represents a substantially large share of either imports or exports. For each major country exporting to Canada, one can thus observe how important Canada is to that exporting country compared to other countries of the world. Chapter 4 does the same, but for exports of natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments originating from Canada, for each major country of destination. In doing so, one can discover the share that Canada has in each major market; this share value is often used as a measure of competitiveness for Canada. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present a the total picture for imports and exports of natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments to and from Canada to and from all other major countries in the world. "Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used as Hormones Excluding Medicaments" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments" is 5415 . SHOW LESS READ MORE >

1 INTRODUCTION AND METHODOLOGY
2 CANADA AND THE WORLD MARKET
2.1 Imports in Canada in 2011
2.2 Exports from Canada in 2011
3 IMPORTS IN CANADA
3.1 Asia
3.1.1 China
3.1.2 Hong Kong
3.1.3 India
3.1.4 Japan
3.1.5 Singapore
3.1.6 Taiwan
3.2 Europe
3.2.1 Austria
3.2.2 Czech Republic
3.2.3 Denmark
3.2.4 France
3.2.5 Germany
3.2.6 Ireland
3.2.7 Italy
3.2.8 Latvia
3.2.9 Portugal
3.2.10 Spain
3.2.11 Sweden
3.2.12 the Netherlands
3.2.13 the United Kingdom
3.3 Latin America
3.3.1 Argentina
3.3.2 Mexico
3.4 North America & the Caribbean
3.4.1 the Bahamas
3.4.2 the United States
3.5 Oceana
3.5.1 Australia
3.5.2 New Zealand
3.6 the Middle East
3.6.1 Israel
4 EXPORTS FROM CANADA
4.1 Europe
4.1.1 France
4.1.2 Germany
4.1.3 Italy
4.1.4 the Netherlands
4.2 Latin America
4.2.1 Brazil
4.2.2 Mexico
4.3 North America & the Caribbean
4.3.1 the United States
4.4 Oceana
4.4.1 Australia
5 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS
5.1 Disclaimers & Safe Harbor
5.2 ICON Group Ltd. User Agreement Provisions